Tilray acquires Ontario subsidiary from MediPharm for 1.37M shares; converts $50M note into 1.03M shares

Tilray Brands, Inc.

Acquired all shares of 1000652011 Ontario Inc. from MediPharm Labs for 1,371,157 Tilray shares; earn-out up to 1,378,843 more if VWAP below $2.3958 by Oct 9, 2023.
Issued 1,032,616 Tilray shares to HT Investments MA LLC upon conversion of $50M convertible note dated July 12, 2022.
Both share issuances are unregistered: Regulation S for MediPharm, Section 3(a)(9) for HTI.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.